TOP NEWS
Home >> Marketplace Directory >> Pembrolizumab plus axitinib approved for RCC

Pembrolizumab plus axitinib approved for RCC

in Marketplace Directory

image_pdfCreate PDF

Merck, 908-740-4000

Pages: 1 2

Tagged with:

CAP TODAY
X